rs587776533
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_022132.5(MCCC2):c.517dupT(p.Ser173PhefsTer25) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000211 in 1,613,758 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. S173S) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_022132.5 frameshift
Scores
Clinical Significance
Conservation
Publications
- 3-methylcrotonyl-CoA carboxylase 2 deficiencyInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- 3-methylcrotonyl-CoA carboxylase deficiencyInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MCCC2 | NM_022132.5 | c.517dupT | p.Ser173PhefsTer25 | frameshift_variant | Exon 6 of 17 | ENST00000340941.11 | NP_071415.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152166Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000199 AC: 5AN: 251444 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461592Hom.: 0 Cov.: 31 AF XY: 0.0000206 AC XY: 15AN XY: 727122 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74330 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
3-methylcrotonyl-CoA carboxylase 2 deficiency Pathogenic:5
- -
- -
- -
- -
This sequence change creates a premature translational stop signal (p.Ser173Phefs*25) in the MCCC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MCCC2 are known to be pathogenic (PMID: 11181649, 22642865). This variant is present in population databases (no rsID available, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with a positive newborn screening result for MCCC2-related disease (PMID: 11170888, 16010683, 22642865). This variant is also known as D172fs. ClinVar contains an entry for this variant (Variation ID: 1919). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
The c.517dupT variant in the MCCC2 gene has been reported previously in association with 3-methylcrotonyl-CoA carboxylase (3-MCC) deficiency (Gallardo et al., 2001; Grunert et al., 2012). The c.517dupT variant is not observed in large population cohorts (Lek et al., 2016). The duplication causes a frameshift starting with codon serine 173, changes this amino acid to a Phenylalanine residue and creates a premature Stop codon at position 25 of the new reading frame, denoted p.Ser173PhefsX25. This pathogenic variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at